Plunkett Research Online: AlloVir Inc

ALLOVIR INC (ALVR) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi.....


ALLOVIR INC

Ticker: ALVR
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 433-2605
Fax:
Address: 139 Main Street
Cambridge, MA 2142 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Vikas SinhaCEO/CFO/Director/President
David HallalChairman of the Board/Director
See More
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture